Thomas Bhatt

Thomas Bhatt is a leader in proton beam therapy and its clinical advantages for sparing normal tissues in cancer treatment. His research has demonstrated the dosimetric superiority of protons over photons for selected tumor sites including pediatric tumors, head and neck, and thoracic malignancies. He has conducted comparative effectiveness studies examining toxicity reduction with proton versus photon radiation. His work has established evidence-based patient selection criteria for proton therapy across multiple cancer types.